Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What did we learn by studying scleroderma fibroblasts?

M Trojanowska1

  • 1Division of Rheumatology & Immunology, Medical University of South Carolina, 9 Charleston, South Carolina 29425, USA. trojanme@musc.edu

Clinical and Experimental Rheumatology
|September 4, 2004
PubMed
Summary

Systemic sclerosis (SSc) fibroblasts overproduce collagen due to deregulated transcription factors. Understanding these factors in SSc fibrotic disease is crucial for developing targeted therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of the oncostatin M/OSM receptor β axis in activating dermal microvascular endothelial cells in systemic sclerosis.

Arthritis research & therapy·2020
Same author

Role of PDGF in fibrotic diseases and systemic sclerosis.

Rheumatology (Oxford, England)·2008
Same author

Endovascular repair of abdominal aortic aneurysms in patients with severe angulation of the proximal neck using a flexible stent-graft: European Multicenter Experience.

The Journal of cardiovascular surgery·2006
Same author

The 72-kilodalton IE-1 protein of human cytomegalovirus (HCMV) is a potent inducer of connective tissue growth factor (CTGF) in human dermal fibroblasts.

Clinical and experimental rheumatology·2004
Same author

Differential regulation of transforming growth factor-beta receptors type I and II by platelet-derived growth factor in human dermal fibroblasts.

The British journal of dermatology·2001
Same author

The inhibitory effects of camptothecin, a topoisomerase I inhibitor, on collagen synthesis in fibroblasts from patients with systemic sclerosis.

Arthritis research·2001

Area of Science:

  • Connective tissue diseases
  • Molecular biology
  • Cell biology

Background:

  • Systemic sclerosis (SSc), or scleroderma, is a fibrotic disease affecting skin and internal organs.
  • SSc fibroblasts exhibit increased collagen and extracellular matrix (ECM) protein synthesis in vitro.
  • These cells are a key model for studying SSc pathogenesis.

Purpose of the Study:

  • To provide an overview of transcription factors deregulated in SSc fibroblasts.
  • To discuss the potential origins of SSc fibroblasts.

Main Methods:

  • Literature review of studies on SSc fibroblasts.
  • Analysis of transcription factor involvement in SSc pathogenesis.

Main Results:

Related Experiment Videos

  • Identified key transcription factors with altered activity in SSc fibroblasts.
  • Highlighted the role of these factors in collagen overproduction.
  • Discussed potential cellular origins contributing to SSc fibroblast phenotype.

    • Conclusions:

    • Deregulated transcription factors are central to the fibrotic phenotype of SSc fibroblasts.
    • Further research into these factors and fibroblast origins may reveal therapeutic targets for SSc.